Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6068)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 14, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang HQ, Zhang WH, Wang YQ, Geng XP, Wang MW, Fan YY, Guan J, Shen JL, Chen X. Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis. World J Gastroenterol 2020; 26(46): 7352-7366 [PMID: 33362389 DOI: 10.3748/wjg.v26.i46.7352] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i46/7352.htm |
| Number | Citing Articles |
| 1 |
Dan Gu, Ting Cao, Shijie Yi, Ya Liu, Chao Fan. CCCTC-Binding Factor Mediates the Transcription of Insulin-Like Growth Factor Binding Protein 5 Through EZH2 in Ulcerative Colitis. Digestive Diseases and Sciences 2023; 68(3): 778 doi: 10.1007/s10620-022-07566-w
|
| 2 |
Xiang Li, Ru-Yi Chen, Jin-Jin Shi, Chang-Yun Li, Yan-Jun Liu, Chang Gao, Ming-Rong Gao, Shun Zhang, Jian-Fei Lu, Jia-Feng Cao, Guan-Jun Yang, Jiong Chen. Emerging role of Jumonji domain-containing protein D3 (JMJD3) in inflammatory diseases. Journal of Pharmaceutical Analysis 2024; : 100978 doi: 10.1016/j.jpha.2024.100978
|
| 3 |
Xuanfu Chen, Lingjuan Jiang, Wei Han, Xiaoyin Bai, Gechong Ruan, Mingyue Guo, Runing Zhou, Haozheng Liang, Hong Yang, Jiaming Qian. Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.742080
|
| 4 |
1,25(OH)2D3 alleviates oxidative stress and inflammation through up-regulating HMGCS2 in DSS-induced colitis. International Immunopharmacology 2023; 125: 111131 doi: 10.1016/j.intimp.2023.111131
|
| 5 |
Yaoyu Guo, Yanni Li, Zeya Tang, Chong Geng, Xiaoxi Xie, Shuailing Song, Chunhui Wang, Xiao Li. Compromised NHE8 Expression Is Responsible for Vitamin D-Deficiency Induced Intestinal Barrier Dysfunction. Nutrients 2023; 15(22): 4834 doi: 10.3390/nu15224834
|
| 6 |
M. S. Boyko, M. V. Osikov, A. A. Fedosov, I. V. Grekova. Clinical and immunological analysis of the effectiveness of local application of vitamin D<sub>3</sub> in experimental colitis. Medical Immunology (Russia) 2023; 25(3): 655 doi: 10.15789/1563-0625-CAI-2685
|
| 7 |
HongQian Wang, Xue He, ShiMin Liang, Xi Chen. Role of vitamin D in ulcerative colitis: an update on basic research and therapeutic applications. Expert Review of Gastroenterology & Hepatology 2022; 16(3): 251 doi: 10.1080/17474124.2022.2048817
|
| 8 |
Zengrong Wu, Deliang Liu, Feihong Deng. The Role of Vitamin D in Immune System and Inflammatory Bowel Disease. Journal of Inflammation Research 2022; : 3167 doi: 10.2147/JIR.S363840
|
| 9 |
Chenyu Liu, Xin Liu, Haitao Shi, Fenrong Chen, Linlang Sun, Xin Gao, Yan Wang. The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2023; 35(12): 1375 doi: 10.1097/MEG.0000000000002670
|